Irbesartan Tablet
Product Images NDC 62135-976

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 62135-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Irbesartan Tablets 150mg 90s Bottle Label)

The label shows Irbesartan Tablets, USP 150 mg in a 90-tablet package by Chartwell RX, LLC. It includes dosage instructions to see the package insert and storage conditions (20° to 25°C). The label features the NDC number 62135-977-90 and a barcode. There is a note indicating 'No Varnish' on the label.*

FDA Label Image

"image Description" (Irbesartan Tablets 300mg 90s Bottle Label)

Label for Irbesartan Tablets, USP 300 mg oral tablets by Chartwell Rx, available in a 90-tablet package. The label includes the NDC 62135-978-90, dosage and storage instructions, and a barcode. The label indicates 'Rx Only' and that the package contains 300 mg tablets.*

FDA Label Image

"image Description" (Irbesartan Tablets 75mg 90s Bottle Label)

Label for Irbesartan Tablets, USP 75 mg by Chartwell RX, LLC. The label indicates it contains 90 tablets, with instructions for use and storage conditions. It also includes a barcode and the NDC number 62135-976-90.*

FDA Label Image

"image Description" (Irbesartan Tablets Graph 1)

Two graphs showing placebo-subtracted reductions in systolic and diastolic blood pressure relative to Irbesartan dose in mg/day. The first graph plots trough systolic blood pressure (SeSBP) reduction, and the second plots trough diastolic blood pressure (SeDBP) reduction, with data points and fitted curves indicating dose-response relationships up to about 900 mg/day.*

FDA Label Image

"image Description" (Irbesartan Tablets Graph 2)

A line graph showing cumulative event rates (%) over months of follow-up (0 to 60) for three groups: AVAPRO, Amlodipine, and Placebo. The AVAPRO group has a lower cumulative event rate over time compared to Amlodipine and Placebo, which have similar higher rates. A legend and a table presenting risk ratios (RR) and p-values comparing AVAPRO versus Placebo and Amlodipine are included in the graph.*

FDA Label Image

"image Description" (Irbesartan Tablets Structure)

Chemical structure diagram of irbesartan, displaying its molecular framework with fused rings and side chains typical for this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.